Skip to main content
SCHOTT Pharma AG & Co. KGaA (FRA: 1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
23.12
+0.08 (0.34%)
At close: Feb 4, 2025

FRA:1SXP Revenue

In the fiscal year ending September 30, 2024, SCHOTT Pharma AG & Co. KGaA had annual revenue of 957.09M EUR with 6.51% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 237.05M in the quarter ending September 30, 2024, with 3.73% growth.

Revenue
957.09M
Revenue Growth
+6.51%
P/S Ratio
n/a
Revenue / Employee
207.88K
Employees
4,690
Market Cap
3.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024957.09M58.49M6.51%
Sep 30, 2023898.60M77.46M9.43%
Sep 30, 2022821.14M172.48M26.59%
Sep 30, 2021648.67M64.44M11.03%
Sep 30, 2020584.23M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SAP SE 34.18B
Deutsche Telekom AG 116.87B
Siemens Aktiengesellschaft 75.93B
Allianz SE 97.41B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München 61.99B
Merck KGaA 20.96B
Siemens Healthineers AG 22.36B
Mercedes-Benz Group AG 147.95B
Revenue Rankings

SCHOTT Pharma AG & Co. KGaA News

More News